Mark Entwistle
Presidente en Chibas Consulting, Inc. .
Cargos activos de Mark Entwistle
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Chibas Consulting, Inc. | Director/Miembro de la Junta | 18/01/2011 | - |
| Presidente | 14/01/2011 | - |
Historial de carrera de Mark Entwistle
Antiguos cargos conocidos de Mark Entwistle.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Director/Miembro de la Junta | 09/10/1997 | - |
Estadísticas
Internacional
| Canadá | 3 |
Operativa
| Director/Board Member | 2 |
| President | 1 |
Sectorial
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
| Chibas Consulting, Inc. |
- Bolsa de valores
- Insiders
- Mark Entwistle
- Experiencia
